ArticleNatural products and bioprospecting2026
Wuchuyuamines A-G, seven new alkaloids isolated from the fruits of Tetradium ruticarpum and their antifungal activities.
Article in Natural products and bioprospecting, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Plant diseases caused by fungal pathogens severely threaten crop yields and food security, driving the need for new, environmentally friendly fungicides. In this study, thirty-six alkaloids, including seven novel ones (1-4, 23, 29, and 30), were isolated from the fruits of Tetradium ruticarpum, and their structures were elucidated by extensive spectroscopic analyses. The antifungal potential of compounds obtained with sufficient quantities was evaluated using the mycelial growth rate method against three phytopathogens (Alternaria solani, Bipolaris sorokiniana, and Fusarium odoratissimum). Compounds 16 and 24 showed notable activity against A. solani, exhibiting approximately 80% and 90% growth inhibition at 100 μg/mL, with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.